Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
- ISBN: 9781420038378 | 1420038370
- Cover:
- Copyright: 8/12/2005
Applied Enzymology, an Overview | |
Introduction | |
Enzymes: Sources and Production | |
Enzymes Used for Analytical Purposes | |
Enzymes Used for Industrial Purposes | |
The Future of Industrial Enzymes | |
Enzyme Engineering | |
Introduction | |
Improving Enzymes by Engineering | |
Engineered Enzyme Properties | |
Engineering Therapeutic Enzymes | |
Conclusions | |
Tissue Plasminogen Activator-Based Thrombolytic Agents | |
Thrombosis and Thrombolytic Therapy | |
Alteplase | |
Reteplase | |
Tenecteplase | |
Conclusions | |
Activated Protein C | |
Structure of APC | |
Development of rhAPC | |
APC Mechanisms of Action | |
APC Pharmacology and Therapeutic Rationale | |
Clinical Development of Drotrecogin Alfa (Activated) for Severe Sepsis | |
Summary and Conclusions | |
Deoxyribonuclease I | |
Introduction | |
Biochemical Aspects | |
Catalytic Mechanism | |
Determination of Activity | |
Therapeutic Applications | |
Production and Stability of rhDNase I | |
Prospects | |
b-Glucocerebrosidase Ceredase“ and Cerezyme“ | |
Introduction | |
Gaucher's Disease | |
Biochemistry | |
Early Attempts at Therapy | |
Development of Ceredase | |
Development of Cerezyme | |
Biochemical Comparison of Cerezyme and Ceredase | |
Clinical Comparisons of Cerezyme and Ceredase | |
Orphan Drug Development Challenges | |
Acknowledgements | |
b-Galactosidase | |
Introduction | |
Detailed Biochemical Characteristics of the Enzyme | |
Fabry's Disease and the Role of Fabrazyme Enzyme Replacement Therapy | |
Development History of the Product | |
Details of Enzyme Product Manufacture | |
Conclusion | |
Acknowledgements | |
Urate Oxidase | |
Introduction | |
Biochemical Characteristics of the Enzyme | |
Indications for which the Enzyme is Approved | |
Developmental History of the Enzyme | |
Characteristics of the Enzyme's Producer Cell Line | |
Enzyme Manufacture Process | |
Main Quality Control Evaluations Undertaken during Production | |
Final Enzyme Product Formulation | |
L-Asparaginase Review of Pharmacology, Drug Resistance, and Clinical Applications | |
Historical Background | |
Pharmacology of L-Asp | |
Mechanism of Action, Drug Resistance, and In Vitro Testing | |
Clinical Applications | |
Adverse Effects | |
Conclusions | |
Recombinant Factor VIIa | |
Introduction | |
Characteristics of the Enzyme | |
Manufacturing Process | |
Indications for which Factor VIIa is Approved | |
Developmental History of the Enzyme | |
Conclusions | |
Factor IX (Protease Zymogen) | |
Introduction | |
Biochemical Properties and Characterization of FIX | |
Hemophilia B | |
Treatment of Hemophilia B | |
rFIX | |
Gene Therapy for Hemophilia B | |
Conclusions | |
The Development of Aldurazyme“ (Laronidase) | |
Introduction and Overview | |
Biochemistry and Genetics of Recombinant µ-L-Iduronidase | |
Clinical Deficiency of µ-L-Iduronidase and MPS I | |
Early Development of ERT | |
Manufacturing of Aldurazyme for the Commercial Market | |
Quality Control System and Assays | |
Clinical Development of Aldurazyme | |
Additional Therapeutic Enzymes | |
Introduction | |
Urokinase | |
Streptokinase | |
Staphylokinase | |
Ancrod | |
Acid µ-Glucosidase | |
Superoxide Dismutase | |
Hyaluronidase | |
Enzymes as Digestive Aids | |
Debriding and Anti-Inflammatory Agents | |
Table of Contents provided by Publisher. All Rights Reserved. |
What is included with this book?
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.